Cellebrite Thomas Hogan Sells 103K Shares: Investor Outlook
Cellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Explore how weekly and monthly automatic buys work for Dividend Aristocrats ETFs and why they can simplify investing. Learn practical steps to set up automatic contributions.
16,919 articlesCellebrite's CEO moved a sizable stake, selling 103,000 shares for about $1.6 million. This article breaks down what ...
Insider trades can offer clues about a company’s near-term path. This article digs into a Mineralys insider banked $5...
When netflix stock fell this past week, investors looked beyond headline results to the quality of communication from...
SoFi shareholders have faced a tough year, but a pair of upbeat bank results offers a new tailwind. This article brea...
Want a fabulous kid’s birthday party without blowing the budget? This guide breaks down practical, doable steps—from ...
Pediatrix (MD) 2025 earnings shaped a cautious optimism about growth and margins in a competitive pediatric care mark...
A major stake sale in Arcellx coincides with fresh competition in the field. This analysis breaks down what happened,...
TJX posted stronger sales, yet its stock fell. This article breaks down the numbers, the market reaction, and practic...
Smart investing in 2026 starts with clear rules. Here are seven practical guidelines, illustrated with Nvidia, Palant...
A single trading session can spark headlines, but smarter investors look at the bigger picture. This guide breaks dow...
With $1,000 to invest, you’re at a crossroads: bet on XRP’s institutional plumbing or Zcash’s privacy-forward store o...
Berkshire Hathaway sits on a large cash cushion while markets move. This article breaks down why patience can shape b...